Quest Diagnostics 2007 Annual Report Download - page 46

Download and view the complete annual report

Please find page 46 of the 2007 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 120

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120

PART III
Item 10. Directors, Executive Officers and Corporate Governance
Our Code of Business Ethics applies to all employees, executive officers and directors, including our Chief
Executive Officer, Chief Financial Officer and Controller. You can find our Code of Business Ethics on our
internet site, www.questdiagnostics.com. We will post any amendments to the Code of Business Ethics, and any
waivers that are required to be disclosed by the rules of either the SEC or the New York Stock Exchange, on
our internet site. You can request a copy of our Code of Business Ethics, at no cost, by contacting Investor
Relations, 3 Giralda Farms, Madison, New Jersey 07940 (973-520-2700).
Because our common stock is listed for trading on the New York Stock Exchange, in 2007 our Chief
Executive Officer was required to make, and he made, an annual certification to the New York Stock Exchange
stating that he was not aware of any violation by Quest Diagnostics of the corporate governance listing standards
of the Exchange. Our Chief Executive Officer made his certification to that effect to the New York Stock
Exchange on approximately May 23, 2007. In addition, we have filed, as exhibits to this Annual Report on Form
10-K, the certifications of our Chief Executive Officer and our Chief Financial Officer required under Section
302 of the Sarbanes-Oxley Act of 2002 to be filed with the SEC regarding the quality of our Company’s public
disclosure.
Information regarding the directors and executive officers of the Company appearing in our Proxy Statement
to be filed by April 28, 2008 (“Proxy Statement”) under the captions “Matters to be Considered at the Meeting –
Election of Directors,” “Information about our Corporate Governance – Audit and Finance Committee,” and
“Additional Information Regarding Executive Compensation – Section 16(a) Beneficial Ownership Reporting
Compliance” is incorporated by reference herein.
Executive Officers of the Registrant
Officers of the Company are elected annually by the Board of Directors and hold office at the discretion of
the Board of Directors. The following persons serve as executive officers of the Company.
Surya N. Mohapatra, Ph.D. (58) is Chairman of the Board, President and Chief Executive Officer. Prior to
joining the Company in February 1999 as Senior Vice President and Chief Operating Officer, he was Senior Vice
President of Picker International, a worldwide leader in advanced medical imaging technologies. Dr. Mohapatra
was appointed President and Chief Operating Officer in June 1999, Chief Executive Officer in May 2004 and
Chairman of the Board in December 2004. He is a director of ITT Corporation. Dr. Mohapatra has been a
director of the Company since 2002.
Robert A. Hagemann (51) is Senior Vice President and Chief Financial Officer. He joined Corning Life
Sciences, Inc. in 1992, where he held a variety of senior financial positions before being named Vice President
and Corporate Controller of the Company in 1996. Mr. Hagemann has served as Chief Financial Officer since
August 1998.
Joan E. Miller, Ph.D. (53) is Senior Vice President – Pathology and Hospital Services. Dr. Miller joined
Corning Life Sciences, Inc. in 1992 and since has held positions of increasing responsibility. Dr. Miller was
named Senior Managing Director, Nichols Institute in 2002 and Vice President, Hospital Business in 2003. Since
June 2007, Dr. Miller has overseen the Company’s hospital services business, including its esoteric testing
facilities, and its anatomic pathology services business, including AmeriPath.
Michael E. Prevoznik (46) is Senior Vice President and General Counsel. Mr. Prevoznik joined the Company
as Vice President and General Counsel in August 1999. In 2003, he assumed responsibility for governmental
affairs. Prior to joining the Company, Mr. Prevoznik served in positions of increasing responsibility within the
compliance organization at SmithKline Beecham, most recently as Vice President, Compliance, with responsibility
for coordinating all SmithKline Beecham compliance activities worldwide.
Wayne R. Simmons (52) is Vice President – Operations. Since July 2007, he has overseen the Company’s
U.S. clinical testing operations. Mr. Simmons joined the Company in February 2004 as Vice President for our
central region. Prior to joining Quest Diagnostics, Mr. Simmons served in positions of increasing responsibility
with Philips Medical Systems, including, since 2002, as Vice President of Supply Chain, in which position he
was responsible for operations at Philips Medical Systems CT Operations facilities globally.
37